Genetic and Epigenetic Determinants of COVID-19 Susceptibility: A Systematic Review.

COVID-19 comorbidities epigenetic genetic molecular mechanisms. novel coronavirus

Journal

Current medicinal chemistry
ISSN: 1875-533X
Titre abrégé: Curr Med Chem
Pays: United Arab Emirates
ID NLM: 9440157

Informations de publication

Date de publication:
19 Jan 2024
Historique:
received: 18 06 2023
revised: 04 08 2023
accepted: 14 11 2023
medline: 22 1 2024
pubmed: 22 1 2024
entrez: 22 1 2024
Statut: aheadofprint

Résumé

The molecular mechanisms regulating coronavirus pathogenesis are complex, including virus-host interactions associated with replication and innate immune control. However, some genetic and epigenetic conditions associated with comorbidities increase the risk of hospitalization and can prove fatal in infected patients. This systematic review will provide insight into host genetic and epigenetic factors that interfere with COVID-19 expression in light of available evidence. This study conducted a systematic review to examine the genetic and epigenetic susceptibility to COVID-19 using a comprehensive approach. Through systematic searches and applying relevant keywords across prominent online databases, including Scopus, PubMed, Web of Science, and Science Direct, we compiled all pertinent papers and reports published in English between December 2019 and June 2023. The findings reveal that the host's HLA genotype plays a substantial role in determining how viral protein antigens are showcased and the subsequent immune system reaction to these antigens. Within females, genes responsible for immune system regulation are found on the X chromosome, resulting in reduced viral load and inflammation levels when contrasted with males. Possessing blood group A may contribute to an increased susceptibility to contracting COVID-19 as well as a heightened risk of mortality associated with the disease. The capacity of SARS-CoV-2 involves inhibiting the antiviral interferon (IFN) reactions, resulting in uncontrolled viral multiplication. There is a notable absence of research into the gender-related predisposition to infection, necessitating a thorough examination. According to the available literature, a significant portion of individuals affected by the ailment or displaying severe ramifications already had suppressed immune systems, categorizing them as a group with elevated risk.

Sections du résumé

BACKGROUND BACKGROUND
The molecular mechanisms regulating coronavirus pathogenesis are complex, including virus-host interactions associated with replication and innate immune control. However, some genetic and epigenetic conditions associated with comorbidities increase the risk of hospitalization and can prove fatal in infected patients. This systematic review will provide insight into host genetic and epigenetic factors that interfere with COVID-19 expression in light of available evidence.
METHODS METHODS
This study conducted a systematic review to examine the genetic and epigenetic susceptibility to COVID-19 using a comprehensive approach. Through systematic searches and applying relevant keywords across prominent online databases, including Scopus, PubMed, Web of Science, and Science Direct, we compiled all pertinent papers and reports published in English between December 2019 and June 2023.
RESULTS RESULTS
The findings reveal that the host's HLA genotype plays a substantial role in determining how viral protein antigens are showcased and the subsequent immune system reaction to these antigens. Within females, genes responsible for immune system regulation are found on the X chromosome, resulting in reduced viral load and inflammation levels when contrasted with males. Possessing blood group A may contribute to an increased susceptibility to contracting COVID-19 as well as a heightened risk of mortality associated with the disease. The capacity of SARS-CoV-2 involves inhibiting the antiviral interferon (IFN) reactions, resulting in uncontrolled viral multiplication.
CONCLUSION CONCLUSIONS
There is a notable absence of research into the gender-related predisposition to infection, necessitating a thorough examination. According to the available literature, a significant portion of individuals affected by the ailment or displaying severe ramifications already had suppressed immune systems, categorizing them as a group with elevated risk.

Identifiants

pubmed: 38251695
pii: CMC-EPUB-137574
doi: 10.2174/0109298673267890231221100659
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Amin Gasmi (A)

Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.

Laura Kassym (L)

Astana Medical University, Astana, Kazakhstan.

Alain Menzel (A)

Laboratoires Réunis, Junglinster, Luxembourg.

Wajiha Anzar (W)

Dow University of Health Sciences, Karachi, Pakistan.

Maryam Dadar (M)

CONEM Iran Microbiology Research Group, Tehran, Iran.

Yuliya Semenova (Y)

Nazarbayev University School of Medicine, Astana, Kazakhstan.

Mehreen Arshad (M)

National University of Sciences and Technology, Islamabad, Pakistan.

Tetyana Bihunyak (T)

I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.

Nagwa Abdel Meguid (NA)

Research on Children with Special Needs Department, National Research Centre, Giza, Egypt.
CONEM Egypt Child Brain Research Group, National Research Center, Giza, Egypt.

Massimiliano Peana (M)

Department of Chemical, Physical, Mathematical and Natural Sciences, University of Sassari, Italy.

Zhanagul Bekbergenova (Z)

Astana Medical University, Astana, Kazakhstan.

Geir Bjørklund (G)

Council for Nutritional and Environmental Medicine (CONEM), Mo i Rana, Norway.

Classifications MeSH